With the rapid success in the development of lipid-RNA nanoparticles for mRNA vaccines against COVID-19 and the creation of several approved RNA-based drugs, RNA therapeutics have demonstrated enormous potentials for many previously untreatable diseases.
Join a panel of four experts with diversified research background in this field as they share with you their most direct experience in the research and development of RNA therapeutics.
This ACS Webinar is moderated by VP and CSO, Gilles Georges of CAS and co-produced with CAS, a division of the American Chemical Society.
Senior Information Scientist, CAS
John P. Cooke
Medical Director of the Center for RNA Therapeutics, and Chief Translational Science Officer, Houston Methodist Research Institute
Associate Professor, Nanotechnology Innovation Center Kansas State,
Kansas State University
Vice President & Chief Scientific Officer, CAS